WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.
Running low on Ozempic or another weight loss drug? A new tracker can help
Telehealth company Ro has rolled out a new tool to track the supply of weight loss drugs like Ozempic and Wegovy across the U.S., as patients struggle with shortages.
Hims & Hers rolls out weight-loss shots much cheaper than Ozempic, Wegovy
Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.
Ozempic maker fires back at Bernie Sanders over claim that the weight loss drug company 'ripped off' Americans
Ozempic maker Novo Nordisk is disputing Sen. Bernie Sanders' claim that the weight loss drug can be produced for Americans at a fraction of its current price.
Costco launches weight loss program for members
Costco members are now getting access to a weight loss program through Sesame. Through the program, they might be able to get highly coveted weight loss medications.
WeightWatchers CEO sends internal memo to employees as stock plummets amid Oprah exit
WeightWatchers CEO Sima Sistani sent a memo to employees trying to reassure them as the company's stock continues to suffer following the news that Oprah Winfrey is leaving the board.
Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug
Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke.
FDA chief sounds alarm over sale of fake weight loss drugs circulating online
FDA Chief Dr. Robert Califf warned that fake weight loss drugs are emerging in response to shortages of Ozempic and other popular GLP-1 agonists, according to Reuters.
Oprah Winfrey leaving WeightWatchers board, shares drop
Oprah Winfrey has made the decision to exit the WeightWatchers board, effective in May. Shares for the company have dropped following the announcement.
Meat substitutes market expected to boom by 2028, with projected growth estimated at $4.4 billion
Research firm Technavio predicted that the meat substitute market would grow $4.4 billion in value between 2023 and 2028, at a CAGR of 11.98%.
Novo Nordisk increasing supply of Wegovy as demand continues to grow
Novo Nordisk says it Is gradually ramping up supply of its sought-after drug Wegovy. However, the company is still warning patients demand will still outpace supply overall.
California bread company sells out of popular croissant after 15,000-person waitlist clears
Hero Bread's croissants recently had a waitlist of 15,000 people. In honor of National Croissant Day, the company listed a new batch of croissants online which sold out in hours.
Experts express concern over pharmaceutical giant Eli Lilly's new website connecting patients to obesity drugs
Eli Lilly, which makes obesity and diabetes drugs like Zepbound and Mounjaro, has launched a new website that connects patients to telehealth services, but the service worries some health experts.
Southwest Airlines celebrated for policy to give a full row to 'passengers of size' for free
TikTokers have recently discovered Southwest Airlines' inclusion policy to provide one or two additional seats to 'passengers of size' at no extra cost.
Colorado poised to ban 'fatphobia' in workplace, housing
Lawmakers in Colorado are expected to pass legislation that bans bias based on “fatphobia" to prevent employers and landlords from discriminating against those who are overweight.
FDA approves Eli Lilly's tirzepatide for weight loss
Eli Lilly's drug tirzepatide was approved by the Food and Drug Administration to help people who are overweight and have a weight-related medical condition lose weight.
Eli Lilly, Novo Nordisk test popular weight loss-related drugs on children
Eli Lilly and Novo Nordisk are seeking to test some of their most popular drugs approved for Type 2 diabetes and weight management in adults on children.
Brain-boosting snacks at work: 5 healthy choices that nutritionists recommend
During the workday, nutritionists reveal the snack choices that help keep our brains sharp and provide a balance of nutrients — here are five wise food choices for on-the-job snacking.
Novo Nordisk shares fall after media report on quality lapses at US plant
Novo Nordisk, a pharmaceutical company, experienced a decline in its stock prices following a report by financial news agency MarketWire.
Want better value out of your hotel stay? 3 ways to achieve it starting now
Here are helpful hacks and smart tips from experts to stretch the value of your hotel stay and save money — involving food, fitness, accommodations and more.